FOLR1 as a therapeutic target in platinum-resistant ovarian carcinoma: unique expression patterns across ovarian carcinoma histotypes and molecular subtypes of low-grade serous carcinoma. - Leung YY; Llaurado-Fernandez M; Cameron A; Da-Anoy A; Cook LC; Hoenisch J; Ghesquiere C; Gaillard S; Schmid J; Dawson A; Bittner M; Kim H; et al. (Journal of gynecologic oncology, 2025)